Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/68201
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCollins, C.-
dc.contributor.authorGibson, R.-
dc.contributor.authorMakrides, M.-
dc.date.issued2011-
dc.identifier.citationLipid Technology, 2011; 23(9):200-202-
dc.identifier.issn0956-666X-
dc.identifier.issn1863-5377-
dc.identifier.urihttp://hdl.handle.net/2440/68201-
dc.description.abstractInfants born prematurely require higher amounts of dietary docosahexaenoic acid (DHA) than can be supplied through current strategies. Increasing the DHA content of breast milk and formula while achievable may not be the most efficacious approach. A new approach is required that enables direct delivery to the infant enabling maximum dose to be achieved as early as possible.-
dc.description.statementofresponsibilityCarmel T. Collins, Robert A. Gibson, Maria Makrides-
dc.language.isoen-
dc.publisherWiley-
dc.rightsCopyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim-
dc.titleThe DINO trial - challenges for translation into clinical practice-
dc.typeJournal article-
dc.identifier.doi10.1002/lite.201100139-
pubs.publication-statusPublished-
dc.identifier.orcidCollins, C. [0000-0003-3308-9948]-
dc.identifier.orcidGibson, R. [0000-0002-8750-525X]-
dc.identifier.orcidMakrides, M. [0000-0003-3832-541X]-
Appears in Collections:Aurora harvest
Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.